Promoting Health through Vitamin D Therapeutics

Improving People's Lives by Treating and Preventing the Clinical Consequences of
Vitamin D Insufficiency and Secondary Hyperparathyroidism

  

Recent News:

OPKO Health Enters into Exclusive Agreement with Japan Tobacco to Develop and Commercialize RAYALDEE in Japan
October 12, 2017

OPKO Health Announces KDIGO Clinical Practice Guideline Update on CKD-MBD
June 22, 2017

OPKO Health Provides Commercial Update for RAYALDEE
June 05, 2017
 
     
 

 

  

© 2018 OPKO Health Inc.- All rights reserved. | Privacy Policy | Terms Of Use